CUSIP: 018119107
What is CUSIP 018119107?
CUSIP 018119107 identifies ALNAQ - ALLENA PHARMACEUTICALS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 018119107:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2022 Q4 | 0 | $0 | -$4,000 | 0 | |
| 2022 Q3 | 237,610 | $4,000 | -$1,485,060 | $0.02 | 1 |
| 2022 Q2 | 8,944,279 | $1,707,000 | +$91,744 | $0.19 | 23 |
| 2022 Q1 | 8,012,930 | $1,853,000 | -$4,034,323 | $0.23 | 24 |
| 2021 Q4 | 16,999,096 | $10,071,000 | -$2,193,581 | $0.59 | 28 |
| 2021 Q3 | 19,921,886 | $17,973,000 | -$2,816,723 | $0.90 | 36 |
| 2021 Q2 | 21,621,246 | $28,107,000 | +$1,619,935 | $1.30 | 28 |
| 2021 Q1 | 20,361,301 | $28,300,000 | +$2,684,848 | $1.39 | 28 |
| 2020 Q4 | 18,474,674 | $23,646,000 | +$7,245,342 | $1.28 | 27 |
| 2020 Q3 | 10,732,741 | $15,886,000 | -$4,238,103 | $1.48 | 22 |
| 2020 Q2 | 13,391,310 | $21,158,098 | +$296,596 | $1.58 | 28 |
| 2020 Q1 | 14,510,999 | $13,963,060 | -$542,474 | $0.96 | 29 |
| 2019 Q4 | 14,451,726 | $39,452,169 | -$3,424,351 | $2.73 | 26 |
| 2019 Q3 | 15,172,034 | $59,776,354 | -$650,010 | $3.94 | 35 |
| 2019 Q2 | 15,332,213 | $62,406,531 | -$6,033,358 | $4.07 | 44 |
| 2019 Q1 | 16,586,721 | $116,439,374 | -$482,964 | $7.02 | 49 |
| 2018 Q4 | 16,661,058 | $90,774,131 | -$325,148 | $5.45 | 49 |
| 2018 Q3 | 17,518,747 | $188,150,127 | -$4,221,875 | $10.74 | 45 |
| 2018 Q2 | 17,713,873 | $230,810,932 | +$9,225,492 | $13.03 | 49 |
| 2018 Q1 | 17,010,401 | $151,702,950 | -$3,502,171 | $11.02 | 41 |
| 2017 Q4 | 17,400,485 | $168,409,462 | +$140,216,462 | $10.06 | 40 |